According to the latest report published by
Credence Research, Inc. “ Western Blotting Market -
Growth, Future Prospects and Competitive Analysis,
2017-2025,” the global western blotting market was valued
at US$ 548.9 Mn in 2016, and is expected to reach US$ 872.5 Mn by
2025, expanding at a CAGR of 5.1% from 2017 to 2025.
Browse the full report
Western Blotting Market - Growth, Future Prospects and Competitive
Analysis, 2017–2025 at
http://www.credenceresearch.com/report/western-blotting-market
Market Insights
Western blotting or protein immunoblot is used for
quantification and detection of specific proteins based on molecular
weight and size. Western blotting contributes significant share in
the overall molecular diagnostics market as this technique is used in
several analytical processes. Western blotting is also considered as
a prime tool for HIV diagnostics due to its high specificity. The
growth of global western blotting market is majorly attributed to
factors such as growing biotechnology research, growing incidence of
HIV/AIDS, and increasing R&D initiatives in the field of
pharmaceuticals and biotechnology, and growing need for personalized
medicine. Further proliferation of proteomics research and
applications is also supporting the high demand for western blotting
products.
Based on the product types, the global western
blotting market is classified into consumables (reagents and kits),
instruments such as blotting systems (wet blotting instruments and
semi-dry blotting instruments) and imagers (chemiluminescent imagers,
fluorescent imagers and others). Among these, reagents and kits
segments account for majority market share and will continue to
dominate the market through the forecast period. Additionally, rapid
adoption of imager systems will contribute to the fastest growth rate
of this segment.
Based on applications, biomedical and biochemical
research segment accounted for the largest revenue share in 2016.
Rising number of R&D activities held by biotechnology and
pharmaceutical companies and growing government funding for such
research for rapid commercialization of breakthrough products are the
key drivers of this segment. On the other hand, it is expected that
disease diagnosis segment will witness the fastest growth during the
forecast period. Significant growth in incidence of HIV/AIDS and
rising prevalence of infectious diseases such as Hepatitis and Lyme
diseases majorly support the growth of this segment.
Browse full report at
http://www.credenceresearch.com/report/western-blotting-market
Considering the usage areas, the global western
blotting market is studied for research and academia, pharmaceuticals
and biotech, disease diagnosis and others. Among these usage areas,
pharmaceuticals and biotech is the largest segment in 2016. However,
due to growing research and development activities, increasing hoard
for rapid commercialization of novel techniques and growing
government funding for research initiatives in will make research and
academia the fastest progressing usage area segment in the overall
western blotting market.
Geographically, North America is the largest
revenue generating regional market for western blotting and will
continue its dominance through the forecast period. Ample
availability of funds for research work, high demand for personalized
medicine, and domicile of major market players in the region makes
North America the largest regional market for western blotting. On
the other hand, rapid outsourcing of research activities, growing
skills and awareness, and high incidence of infectious diseases will
contribute to the highest growth rate of Asia Pacific market.
Download Free Sample Request:
http://www.credenceresearch.com/sample-request/58630
The global western blotting market is highly
competitive in nature and is also characterized by the presence of
several large and small-sized companies. Some of the major players
observed in this market are Advansta, Inc., Bio-Rad Laboratories,
Inc., Bio-Techne Corporation, Cell Signaling Technology, F.
Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Merck
KGaA, PerkinElmer, Inc., Sigma-Aldrich Co., Thermo Fisher Scientific,
Inc. and Trinity Biotech plc.
Blog:
http://www.technicaltop.com/2017/08/23/western-blotting-market-global-industry-size-share-growth-trends-outlook-opportunities-and-forecast-2017-to-2025/
About
Us
Credence
Research is a worldwide market research and counseling firm that
serves driving organizations, governments, non legislative
associations, and not-for-benefits. We offer our customers some
assistance with making enduring enhancements to their execution and
understand their most imperative objectives. Over almost a century,
we've manufactured a firm extraordinarily prepared to this task.
Who
we are
Credence
Research is a worldwide firm, containing more than 15 research
consultants and almost 100 research and information professionals.
Our
customers mirror our worldwide nature. Around 45% are in Europe, 30%
in the Americas, 13% in Asia Pacific and 12% in the Middle East and
Africa.
Our
firm is intended to work as one. We are a solitary global research
organization united by a solid arrangement of qualities, concentrated
on customer effect.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429,
SAN JOSE,
CA 95103, United States
CA 95103, United States
Ph: 1-800-361-8290
E-mail: sales@credenceresearch.com
Website: http://www.credenceresearch.com
No comments:
Post a Comment